K. Noda et al., Release of endothelial nitric oxide in coronary arteries by celiprolol, a beta(1)-adrenoceptor antagonist: possible clinical relevance, EUR J PHARM, 415(2-3), 2001, pp. 209-216
Mechanisms underlying celiprolol-induced vasodilatation were analyzed in is
olated porcine coronary arteries. Celiprolol induced dose-related relaxatio
n of the artery rings with endothelium, an effect which was suppressed by N
G-nitro-L-arginine methylester (L-NAME), nitric oxide (NO) scavenger, guany
late cyclase inhibitor, endothelium denudation, and removal of Ca2+. L-NAME
contracted, and superoxide dismutase relaxed, the arteries only when the e
ndothelium was preserved. Neither superoxide dismutase nor P-adrenoceptor a
ntagonists changed celiprolol-induced relaxations. Celiprolol increased the
cyclic GMP content in the tissue. The release of NO from endothelium, esti
mated by the extracellular production of cyclic GMP in arteries incubated i
n medium containing guanylate cyclase and GTP, was augmented by celiprolol,
and L-NAME abolished this action of celiprolol. It is concluded that celip
rolol elicits relaxation by acting on sites other than P-adrenoceptors in t
he endothelium and by releasing NO, which activates soluble guanylate cycla
se in smooth muscle and produces cyclic GMP. Scavenging of superoxide anion
s from the endothelium does not seem to account for the induced relaxation.
(C) 2001 Elsevier Science B.V. All rights reserved.